We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

ICDs Can Save Many Lives

By HospiMedica staff writers
Posted on 01 Feb 2005
A new landmark study has shown that the use of an implantable cardioverter-defibrillator (ICD) in patients with heart failure can reduce deaths by 23%. More...
The results were reported in the January 20, 2005, issue of The New England Journal of Medicine.

The study involved 2,521 patients in 150 medical centers in Canada, New Zealand, and the United States with moderate heart failure and poor heart-pumping function who had not experienced sudden cardiac arrest (SCA). An ICD shocks the heart out of a rapid, chaotic heart rhythm that otherwise can lead to death within minutes. The study compared the benefits of ICDs with those of amiodarone, a commonly used heart medication.

The study was sponsored by the U.S. National Institutes of Health (Bethesda, MD, USA), with funding and therapy donations from Wyeth Pharmaceuticals and Medtronic, Inc. After the study was finished, Medtronic, a developer and marketer of ICDs, offered free ICDs to all interested participants who had been randomized to a non-ICD study arm. Implantable defibrillators have been approved for use since the late 1980s, but primarily for the 5% of patients who had already survived an SCA episode.

"This is the first time we have concrete evidence that many people with heart failure will die from sudden cardiac arrest if they don't have an implanted defibrillator,” said Richard Luceri, M.D., of Florida Arrhythmia Consultants/Holy Cross Hospital (Fort Lauderdale, FL, USA). "People with heart failure can be evaluated with a simple test called an echocardiogram to determine if they are at risk for sudden cardiac arrest.”




Related Links:
U.S. National Institutes of Health

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Resorbable Bovine Collagen Membrane
GenDerm
New
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.